tm logo
SPECTRUM PHARMACEUTICALS, INC.
Live/Registered
REGISTERED AND RENEWED

on 15 Nov 2018

Last Applicant/ Owned by

Suite 300

Lake Forest

IL

60045

Serial Number

78814836 filed on 14th Feb 2006

Registration Number

3414581 registered on 22nd Apr 2008

in the Principal Register

Correspondent Address

Tim Burgdorf

Global Patent Group, LLC

2275 Cassens Drive

Suite 118

St. Louis,MO 63026

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

"PHARMACEUTICALS, INC."

SPECTRUM PHARMACEUTICALS, INC.

"PHARMACEUTICALS, INC." Pharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of [ bacterial infections; fungal infections and inflammatory, nephrological, neurological, ] oncological, and urological conditions and diseases

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, those for the treatment, prevention, and diagnosis of [ bacterial infections; fungal infections and inflammatory, nephrological, neurological, ] oncological, and urological conditions and diseases


First Use Date in General

01st Oct 2004

First Use Date in Commerce

05th Nov 2004

Mark Details


Serial Number

No 78814836

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SPECTRUM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Jan 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
17th Jan 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17th Jan 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17th Jan 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17th Jan 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Aug 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
15th Nov 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
15th Nov 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
15th Nov 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
24th Oct 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED